Independent minds. Global perspective. A publication for the builders
Biotechnology / San Francisco

Mike Polcari.

Founder
Haplotype Labs

Mike Polcari founded Haplotype Labs, which develops software for managing genetic data and deploying analytical models. His public biography describes architecture leadership at 23andMe. The HaploHub platform serves laboratories and clinical organizations, combining data hosting, inference workflows, and reports within an interface that does not require custom code.

Public-source researchLast checked 1 source ↘
THE STORY, IN CONTEXT

Mike Polcari and the story of Haplotype Labs.

Haplotype Labs's public launch connects Polcari's experience building genetic-reporting technology with a desire to make similar infrastructure available to other organizations. The product brings data management and model execution together rather than focusing on a single risk score. The supplied evidence establishes that platform direction without independently validating disease prediction, prevention benefits, clinical utility, or the handling of sensitive genetic information in a particular deployment.

FROM THE PUBLIC RECORD

Public advice & further reading.

No personal advice is attributed in this profile: a verifiable public advice source has not yet been established. The company and activity facts above remain separately sourced.

Suggest a first-person interview or essay ↗
EVIDENCE IN PLAIN SIGHT

Sources & attribution.

  1. 01
    Haplotype Labs — Y Combinator company and active founder profile

    Public active-founder biography, current company status and description, and founding-team launch accounts. Company or team statements are attributed accounts, not independently audited performance results.

    www.ycombinator.com
About this profile

Independently researched from the public sources above. Featured people and companies are not affiliated with BusinessBlogz. Source dates and attribution provide context for the information shown; business claims remain attributed to their original source. Role and company details can change after review. The initials graphic is editorial artwork, not a photograph.

Request a correction or update ↗
KEEP EXPLORING

More builders in Biotechnology.

Explore the sector ↗